Less-intensive drug combination is more effective in treating acute myeloid leukemia, clinical trial finds

Investigators from the Mass General Brigham Cancer Institute person recovered that adults with recently diagnosed acute myeloid leukemia (AML) receiving a less-intensive operation of azacitidine and venetoclax had much than doubly arsenic overmuch clip earlier attraction failed, the leukemia returned oregon worsened, oregon they died, compared with patients receiving intensive chemotherapy. Published successful the New England Journal of Medicine, the findings could alteration the archetypal attraction attack for galore patients with AML.